Revance Therapeutics (RVNC) delivered earnings and revenue surprises of -5.71% and 11.60%, respectively, for the quarter ended Sept. Do the numbers hold clues to what lies ahead for the stock?

The big lawsuits that upended real estate industry commissions got a lot of attention for buyers, but sellers also face new terrain and hard choices.

Investors are digesting a fresh interest rate cut from the Federal Reserve as the impact of Trump's expected policies also remains in focus.

The FTSE 100 (^FTSE) and European stocks were lower on Thursday after the Federal Reserve followed the Bank of England in ...

"In the near term, the election will have no effects on our policy decisions. As you know, many, many things affect the ...

Palantir (NYSE:PLTR) stock has been downgraded from Hold to Underperform at Jefferies as the firm cites concerns over the company's high valuation following the latest rally.

WonderFi CEO Dean Skurka was briefly held by unknown assailants in Toronto until a ransom was paid. Skurka is unharmed. The ...

Outsourcing group Serco today said it faces a £20 million a year hit from changes announced in last week’s Budget. Serco, ...

Wednesday wasn’t just a good day for Donald Trump. The wealth of the world’s 10 richest people also soared by a record amount ...

Volkswagen is recalling 114,478 vehicles in the US because of safety concerns over their airbags, the National Highway ...

Top 10 Stocks. In this article, we are going to take a look at where Amazon (NASDAQ:AMZN) stands against the other stocks in ...

Thank you for holding, and welcome to Rockwell Automation's Quarterly Conference Call. I need to remind everyone that today's conference call is being recorded. (Operator Instructions) At this time, I ...